In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions

Journal of Infectious Diseases

Volumn 177, Issue 5, 1998, Pages 1398-1401

  Van Der Laken, Conny J ^a   Boerman, Otto C ^a   Oyen, Wim J G ^a   Laverman, Peter ^a   Van De Yen, Marjo T P ^a   Corstens, Frans H M ^a   Van Der Meer, Jos W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CANDIDA ALBICANS; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRANULOCYTE; INFLAMMATION; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

EID: 0031924685     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517823     Document Type: Article

References (15)

1. Sims JE, Gayle MA, Slack JL, et al. Interleukin-1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 1993;90: 6155-9.
2. Deyerle KL, Sims JE, Dower SK, Bothwell MA. Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J Immunol 1992; 149:1657-65.
3. Van der Laken CJ, Boerman OC, Oyen WJG, et al. Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. Eur J Nucl Med 1995;22:1249-55.
4. Van der Laken CJ, Boerman OC, Oyen WJG, et al. Preferential localization of systemically administered radiolabeled interleukin-1 alpha in experimental inflammation in mice by binding to the type II receptor. J Clin Invest 1997; 100:2970-6.
5. Sambrook J, Fritsch EF, Maniatis T, eds. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989; 1.42-3.
6. Bristulf J, Bartfai T. Interleukin-1β and tumour necrosis factor-α stimulate the mRNA expression of interleukin-1 receptors in mouse anterior pituitary AtT-20 cells. Neurosci Lett 1995; 187:53-6.
7. Netea MG, Drenth JPH, De Bont N, et al. A semi-quantitative reverse transcriptase polymerase chain reaction method for measurement of mRNA for TNF-a and IL-1β in whole blood cultures: its application in typhoid fever and exentric exercise. Cytokine 1996; 8:739-44.
8. Spriggs MK, Nevens PJ, Grabstein K, et al. Molecular characterization of the interleukin-1 receptor (IL-1R) on monocytes and polymorphonuclear cells. Cytokine 1992;4:90-5.
9. Chizzonite R, Truitt T, Kilian PL, et al. Two high-affinity interleukin-1 receptors represent separate gene products. Proc Natl Acad Sci USA 1989; 86:8029-33.
10. Boraschi D, Rambaldi A, Sica A, et al. Endothelial cells express the interleukin-1 receptor type I. Blood 1991;78:1262-7.
11. Sims JE, Acres RB, Grubin CE, et al. Cloning the interleukin-1 receptor from human T-cells. Proc Natl Acad Sci USA 1989; 86:8946-50.
12. Parnet P, Amindari S, Wu C, et al. Expression of type I and type II interleukin-1 receptors in mouse brain. Brain Res Mol Brain Res 1994; 27:63-70.
13. Wong H, Anderson WD, Cheng T, Riabowol KT. Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal Biochem 1994;223:251-8.
14. Jain RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res 1990;50:814S-9S.
15. Colotta F, Re F, Muzio M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993;261:472-5.